Loading…
Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction
J. Neurochem. (2010) 114, 1193-1204. We have shown previously that the plecomacrolide antibiotics bafilomycin A1 and B1 significantly attenuate cerebellar granule neuron death resulting from agents that disrupt lysosome function. To further characterize bafilomycin-mediated cytoprotection, we examin...
Saved in:
Published in: | Journal of neurochemistry 2010-08, Vol.114 (4), p.1193-1204 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5868-fbb611ceb513a9eec9ccda689ce187f7be1de1640182adb7fb5f4bc220d616a93 |
---|---|
cites | cdi_FETCH-LOGICAL-c5868-fbb611ceb513a9eec9ccda689ce187f7be1de1640182adb7fb5f4bc220d616a93 |
container_end_page | 1204 |
container_issue | 4 |
container_start_page | 1193 |
container_title | Journal of neurochemistry |
container_volume | 114 |
creator | Pivtoraiko, Violetta N Harrington, Adam J Mader, Burton J Luker, Austin M Caldwell, Guy A Caldwell, Kim A Roth, Kevin A Shacka, John J |
description | J. Neurochem. (2010) 114, 1193-1204. We have shown previously that the plecomacrolide antibiotics bafilomycin A1 and B1 significantly attenuate cerebellar granule neuron death resulting from agents that disrupt lysosome function. To further characterize bafilomycin-mediated cytoprotection, we examined its ability to attenuate the death of naïve and differentiated neuronal SH-SY5Y human neuroblastoma cells from agents that induce lysosome dysfunction in vitro, and from in vivo dopaminergic neuron death in C. elegans. Low-dose bafilomycin significantly attenuated SH-SY5Y cell death resulting from treatment with chloroquine, hydroxychloroquine amodiaquine and staurosporine. Bafilomycin also attenuated the chloroquine-induced reduction in processing of cathepsin D, the principal lysosomal aspartic acid protease, to its mature 'active' form. Chloroquine induced autophagic vacuole accumulation and inhibited autophagic flux, effects that were attenuated upon treatment with bafilomycin and were associated with a significant decrease in chloroquine-induced accumulation of detergent-insoluble α-synuclein oligomers. In addition, bafilomycin significantly and dose-dependently attenuated dopaminergic neuron death in C. elegans resulting from in vivo over-expression of human wild-type α-synuclein. Together, our findings suggest that low-dose bafilomycin is cytoprotective in part through its maintenance of the autophagy-lysosome pathway, and underscores its therapeutic potential for treating Parkinson's disease and other neurodegenerative diseases that exhibit disruption of protein degradation pathways and accumulation of toxic protein species. |
doi_str_mv | 10.1111/j.1471-4159.2010.06838.x |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2910188</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2110933131</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5868-fbb611ceb513a9eec9ccda689ce187f7be1de1640182adb7fb5f4bc220d616a93</originalsourceid><addsrcrecordid>eNqNkcuu0zAQhi0E4pQDrwAWEmKV4kviOAuQUMVVFSzgrK2JY7eOErvECT15exxaymWFN77M949n5kcIU7Kmab1o1zQvaZbTolozkl6JkFyub--g1SVwF60IYSzjJGdX6EGMLSFU5ILeR1eMFDwnhKxQuw3HrAnR4Bqs60I_a-cxjKPxE4wmYm-mIXjosDZdhxsD4x5DjEG7FG7w0S33aQyHPezmrJtjiKE3-JC4I8y4maOdvB5d8A_RPQtdNI_O-zW6efvm6-Z9tv387sPm9TbThRQys3UtKNWmLiiHyhhdad2AkJU2VJa2rA1tTGqEUMmgqUtbFzavNWOkEVRAxa_Rq1Pew1T3ptHGjwN06jC4HoZZBXDq74h3e7UL3xWraEoqU4Ln5wRD-DaZOKrexaV98CZMUZVFXhRSEp7Ip_-QbZiGNK0E5WnALGciQfIE6SHEOBh7KYUStdipWrW4phbX1GKn-mmnuk3Sx3-2chH-8i8Bz84ARA2dHcBrF39znJQFlyxxL0_c0XVm_u8C1MdPm-WU9E9OegtBwW5If9x8SSRPAxOC04r_AARKyGQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>744002426</pqid></control><display><type>article</type><title>Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction</title><source>Wiley-Blackwell Read & Publish Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Pivtoraiko, Violetta N ; Harrington, Adam J ; Mader, Burton J ; Luker, Austin M ; Caldwell, Guy A ; Caldwell, Kim A ; Roth, Kevin A ; Shacka, John J</creator><creatorcontrib>Pivtoraiko, Violetta N ; Harrington, Adam J ; Mader, Burton J ; Luker, Austin M ; Caldwell, Guy A ; Caldwell, Kim A ; Roth, Kevin A ; Shacka, John J</creatorcontrib><description>J. Neurochem. (2010) 114, 1193-1204. We have shown previously that the plecomacrolide antibiotics bafilomycin A1 and B1 significantly attenuate cerebellar granule neuron death resulting from agents that disrupt lysosome function. To further characterize bafilomycin-mediated cytoprotection, we examined its ability to attenuate the death of naïve and differentiated neuronal SH-SY5Y human neuroblastoma cells from agents that induce lysosome dysfunction in vitro, and from in vivo dopaminergic neuron death in C. elegans. Low-dose bafilomycin significantly attenuated SH-SY5Y cell death resulting from treatment with chloroquine, hydroxychloroquine amodiaquine and staurosporine. Bafilomycin also attenuated the chloroquine-induced reduction in processing of cathepsin D, the principal lysosomal aspartic acid protease, to its mature 'active' form. Chloroquine induced autophagic vacuole accumulation and inhibited autophagic flux, effects that were attenuated upon treatment with bafilomycin and were associated with a significant decrease in chloroquine-induced accumulation of detergent-insoluble α-synuclein oligomers. In addition, bafilomycin significantly and dose-dependently attenuated dopaminergic neuron death in C. elegans resulting from in vivo over-expression of human wild-type α-synuclein. Together, our findings suggest that low-dose bafilomycin is cytoprotective in part through its maintenance of the autophagy-lysosome pathway, and underscores its therapeutic potential for treating Parkinson's disease and other neurodegenerative diseases that exhibit disruption of protein degradation pathways and accumulation of toxic protein species.</description><identifier>ISSN: 0022-3042</identifier><identifier>EISSN: 1471-4159</identifier><identifier>DOI: 10.1111/j.1471-4159.2010.06838.x</identifier><identifier>PMID: 20534000</identifier><identifier>CODEN: JONRA9</identifier><language>eng</language><publisher>Oxford, UK: Oxford, UK : Blackwell Publishing Ltd</publisher><subject>Animals ; Antibiotics ; autophagy ; Autophagy - drug effects ; Autophagy - physiology ; bafilomycin ; Biochemistry ; Biological and medical sciences ; Caenorhabditis elegans - drug effects ; cathepsin D ; Cell Line, Tumor ; Cellular biology ; Cytoprotection - drug effects ; Cytoprotection - physiology ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Disease Progression ; Humans ; lysosome ; Lysosomes - drug effects ; Lysosomes - physiology ; Macrolides - pharmacology ; Medical sciences ; Nerve Degeneration - drug therapy ; Nerve Degeneration - metabolism ; Nerve Degeneration - pathology ; Neurology ; Neurons ; Neurons - drug effects ; Neurons - metabolism ; Parkinson disease ; Parkinson’s Disease ; Signal Transduction - drug effects ; Tumors of the nervous system. Phacomatoses ; α-synuclein</subject><ispartof>Journal of neurochemistry, 2010-08, Vol.114 (4), p.1193-1204</ispartof><rights>2010 The Authors. Journal Compilation © 2010 International Society for Neurochemistry</rights><rights>2015 INIST-CNRS</rights><rights>Journal compilation © 2010 International Society for Neurochemistry</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5868-fbb611ceb513a9eec9ccda689ce187f7be1de1640182adb7fb5f4bc220d616a93</citedby><cites>FETCH-LOGICAL-c5868-fbb611ceb513a9eec9ccda689ce187f7be1de1640182adb7fb5f4bc220d616a93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23075382$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20534000$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pivtoraiko, Violetta N</creatorcontrib><creatorcontrib>Harrington, Adam J</creatorcontrib><creatorcontrib>Mader, Burton J</creatorcontrib><creatorcontrib>Luker, Austin M</creatorcontrib><creatorcontrib>Caldwell, Guy A</creatorcontrib><creatorcontrib>Caldwell, Kim A</creatorcontrib><creatorcontrib>Roth, Kevin A</creatorcontrib><creatorcontrib>Shacka, John J</creatorcontrib><title>Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction</title><title>Journal of neurochemistry</title><addtitle>J Neurochem</addtitle><description>J. Neurochem. (2010) 114, 1193-1204. We have shown previously that the plecomacrolide antibiotics bafilomycin A1 and B1 significantly attenuate cerebellar granule neuron death resulting from agents that disrupt lysosome function. To further characterize bafilomycin-mediated cytoprotection, we examined its ability to attenuate the death of naïve and differentiated neuronal SH-SY5Y human neuroblastoma cells from agents that induce lysosome dysfunction in vitro, and from in vivo dopaminergic neuron death in C. elegans. Low-dose bafilomycin significantly attenuated SH-SY5Y cell death resulting from treatment with chloroquine, hydroxychloroquine amodiaquine and staurosporine. Bafilomycin also attenuated the chloroquine-induced reduction in processing of cathepsin D, the principal lysosomal aspartic acid protease, to its mature 'active' form. Chloroquine induced autophagic vacuole accumulation and inhibited autophagic flux, effects that were attenuated upon treatment with bafilomycin and were associated with a significant decrease in chloroquine-induced accumulation of detergent-insoluble α-synuclein oligomers. In addition, bafilomycin significantly and dose-dependently attenuated dopaminergic neuron death in C. elegans resulting from in vivo over-expression of human wild-type α-synuclein. Together, our findings suggest that low-dose bafilomycin is cytoprotective in part through its maintenance of the autophagy-lysosome pathway, and underscores its therapeutic potential for treating Parkinson's disease and other neurodegenerative diseases that exhibit disruption of protein degradation pathways and accumulation of toxic protein species.</description><subject>Animals</subject><subject>Antibiotics</subject><subject>autophagy</subject><subject>Autophagy - drug effects</subject><subject>Autophagy - physiology</subject><subject>bafilomycin</subject><subject>Biochemistry</subject><subject>Biological and medical sciences</subject><subject>Caenorhabditis elegans - drug effects</subject><subject>cathepsin D</subject><subject>Cell Line, Tumor</subject><subject>Cellular biology</subject><subject>Cytoprotection - drug effects</subject><subject>Cytoprotection - physiology</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Disease Progression</subject><subject>Humans</subject><subject>lysosome</subject><subject>Lysosomes - drug effects</subject><subject>Lysosomes - physiology</subject><subject>Macrolides - pharmacology</subject><subject>Medical sciences</subject><subject>Nerve Degeneration - drug therapy</subject><subject>Nerve Degeneration - metabolism</subject><subject>Nerve Degeneration - pathology</subject><subject>Neurology</subject><subject>Neurons</subject><subject>Neurons - drug effects</subject><subject>Neurons - metabolism</subject><subject>Parkinson disease</subject><subject>Parkinson’s Disease</subject><subject>Signal Transduction - drug effects</subject><subject>Tumors of the nervous system. Phacomatoses</subject><subject>α-synuclein</subject><issn>0022-3042</issn><issn>1471-4159</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqNkcuu0zAQhi0E4pQDrwAWEmKV4kviOAuQUMVVFSzgrK2JY7eOErvECT15exxaymWFN77M949n5kcIU7Kmab1o1zQvaZbTolozkl6JkFyub--g1SVwF60IYSzjJGdX6EGMLSFU5ILeR1eMFDwnhKxQuw3HrAnR4Bqs60I_a-cxjKPxE4wmYm-mIXjosDZdhxsD4x5DjEG7FG7w0S33aQyHPezmrJtjiKE3-JC4I8y4maOdvB5d8A_RPQtdNI_O-zW6efvm6-Z9tv387sPm9TbThRQys3UtKNWmLiiHyhhdad2AkJU2VJa2rA1tTGqEUMmgqUtbFzavNWOkEVRAxa_Rq1Pew1T3ptHGjwN06jC4HoZZBXDq74h3e7UL3xWraEoqU4Ln5wRD-DaZOKrexaV98CZMUZVFXhRSEp7Ip_-QbZiGNK0E5WnALGciQfIE6SHEOBh7KYUStdipWrW4phbX1GKn-mmnuk3Sx3-2chH-8i8Bz84ARA2dHcBrF39znJQFlyxxL0_c0XVm_u8C1MdPm-WU9E9OegtBwW5If9x8SSRPAxOC04r_AARKyGQ</recordid><startdate>201008</startdate><enddate>201008</enddate><creator>Pivtoraiko, Violetta N</creator><creator>Harrington, Adam J</creator><creator>Mader, Burton J</creator><creator>Luker, Austin M</creator><creator>Caldwell, Guy A</creator><creator>Caldwell, Kim A</creator><creator>Roth, Kevin A</creator><creator>Shacka, John J</creator><general>Oxford, UK : Blackwell Publishing Ltd</general><general>Blackwell Publishing Ltd</general><general>Wiley-Blackwell</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>5PM</scope></search><sort><creationdate>201008</creationdate><title>Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction</title><author>Pivtoraiko, Violetta N ; Harrington, Adam J ; Mader, Burton J ; Luker, Austin M ; Caldwell, Guy A ; Caldwell, Kim A ; Roth, Kevin A ; Shacka, John J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5868-fbb611ceb513a9eec9ccda689ce187f7be1de1640182adb7fb5f4bc220d616a93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Antibiotics</topic><topic>autophagy</topic><topic>Autophagy - drug effects</topic><topic>Autophagy - physiology</topic><topic>bafilomycin</topic><topic>Biochemistry</topic><topic>Biological and medical sciences</topic><topic>Caenorhabditis elegans - drug effects</topic><topic>cathepsin D</topic><topic>Cell Line, Tumor</topic><topic>Cellular biology</topic><topic>Cytoprotection - drug effects</topic><topic>Cytoprotection - physiology</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Disease Progression</topic><topic>Humans</topic><topic>lysosome</topic><topic>Lysosomes - drug effects</topic><topic>Lysosomes - physiology</topic><topic>Macrolides - pharmacology</topic><topic>Medical sciences</topic><topic>Nerve Degeneration - drug therapy</topic><topic>Nerve Degeneration - metabolism</topic><topic>Nerve Degeneration - pathology</topic><topic>Neurology</topic><topic>Neurons</topic><topic>Neurons - drug effects</topic><topic>Neurons - metabolism</topic><topic>Parkinson disease</topic><topic>Parkinson’s Disease</topic><topic>Signal Transduction - drug effects</topic><topic>Tumors of the nervous system. Phacomatoses</topic><topic>α-synuclein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pivtoraiko, Violetta N</creatorcontrib><creatorcontrib>Harrington, Adam J</creatorcontrib><creatorcontrib>Mader, Burton J</creatorcontrib><creatorcontrib>Luker, Austin M</creatorcontrib><creatorcontrib>Caldwell, Guy A</creatorcontrib><creatorcontrib>Caldwell, Kim A</creatorcontrib><creatorcontrib>Roth, Kevin A</creatorcontrib><creatorcontrib>Shacka, John J</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of neurochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pivtoraiko, Violetta N</au><au>Harrington, Adam J</au><au>Mader, Burton J</au><au>Luker, Austin M</au><au>Caldwell, Guy A</au><au>Caldwell, Kim A</au><au>Roth, Kevin A</au><au>Shacka, John J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction</atitle><jtitle>Journal of neurochemistry</jtitle><addtitle>J Neurochem</addtitle><date>2010-08</date><risdate>2010</risdate><volume>114</volume><issue>4</issue><spage>1193</spage><epage>1204</epage><pages>1193-1204</pages><issn>0022-3042</issn><eissn>1471-4159</eissn><coden>JONRA9</coden><abstract>J. Neurochem. (2010) 114, 1193-1204. We have shown previously that the plecomacrolide antibiotics bafilomycin A1 and B1 significantly attenuate cerebellar granule neuron death resulting from agents that disrupt lysosome function. To further characterize bafilomycin-mediated cytoprotection, we examined its ability to attenuate the death of naïve and differentiated neuronal SH-SY5Y human neuroblastoma cells from agents that induce lysosome dysfunction in vitro, and from in vivo dopaminergic neuron death in C. elegans. Low-dose bafilomycin significantly attenuated SH-SY5Y cell death resulting from treatment with chloroquine, hydroxychloroquine amodiaquine and staurosporine. Bafilomycin also attenuated the chloroquine-induced reduction in processing of cathepsin D, the principal lysosomal aspartic acid protease, to its mature 'active' form. Chloroquine induced autophagic vacuole accumulation and inhibited autophagic flux, effects that were attenuated upon treatment with bafilomycin and were associated with a significant decrease in chloroquine-induced accumulation of detergent-insoluble α-synuclein oligomers. In addition, bafilomycin significantly and dose-dependently attenuated dopaminergic neuron death in C. elegans resulting from in vivo over-expression of human wild-type α-synuclein. Together, our findings suggest that low-dose bafilomycin is cytoprotective in part through its maintenance of the autophagy-lysosome pathway, and underscores its therapeutic potential for treating Parkinson's disease and other neurodegenerative diseases that exhibit disruption of protein degradation pathways and accumulation of toxic protein species.</abstract><cop>Oxford, UK</cop><pub>Oxford, UK : Blackwell Publishing Ltd</pub><pmid>20534000</pmid><doi>10.1111/j.1471-4159.2010.06838.x</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3042 |
ispartof | Journal of neurochemistry, 2010-08, Vol.114 (4), p.1193-1204 |
issn | 0022-3042 1471-4159 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2910188 |
source | Wiley-Blackwell Read & Publish Collection; Free Full-Text Journals in Chemistry |
subjects | Animals Antibiotics autophagy Autophagy - drug effects Autophagy - physiology bafilomycin Biochemistry Biological and medical sciences Caenorhabditis elegans - drug effects cathepsin D Cell Line, Tumor Cellular biology Cytoprotection - drug effects Cytoprotection - physiology Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Disease Progression Humans lysosome Lysosomes - drug effects Lysosomes - physiology Macrolides - pharmacology Medical sciences Nerve Degeneration - drug therapy Nerve Degeneration - metabolism Nerve Degeneration - pathology Neurology Neurons Neurons - drug effects Neurons - metabolism Parkinson disease Parkinson’s Disease Signal Transduction - drug effects Tumors of the nervous system. Phacomatoses α-synuclein |
title | Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T02%3A31%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low-dose%20bafilomycin%20attenuates%20neuronal%20cell%20death%20associated%20with%20autophagy-lysosome%20pathway%20dysfunction&rft.jtitle=Journal%20of%20neurochemistry&rft.au=Pivtoraiko,%20Violetta%20N&rft.date=2010-08&rft.volume=114&rft.issue=4&rft.spage=1193&rft.epage=1204&rft.pages=1193-1204&rft.issn=0022-3042&rft.eissn=1471-4159&rft.coden=JONRA9&rft_id=info:doi/10.1111/j.1471-4159.2010.06838.x&rft_dat=%3Cproquest_pubme%3E2110933131%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5868-fbb611ceb513a9eec9ccda689ce187f7be1de1640182adb7fb5f4bc220d616a93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=744002426&rft_id=info:pmid/20534000&rfr_iscdi=true |